Table 1 Correlation of NSUN2 expression and clinical features in patients with PC.
From: NSUN2 stimulates tumor progression via enhancing TIAM2 mRNA stability in pancreatic cancer
Variables | NSUN2 expression | Â | |
|---|---|---|---|
Low (n = 15) | High (n = 67) | P value | |
Gender | Â | Â | 0.165 |
Male | 11 | 36 | |
Female | 4 | 31 | |
Age(years) | Â | Â | 0.336 |
<60 | 6 | 36 | |
≥60 | 9 | 31 | |
Tumor differentiation | Â | Â | 0.48 |
Poor | 5 | 29 | |
Well | 10 | 38 | |
Tumor size (cm) | Â | Â | 0.581 |
<4 | 8 | 30 | |
≥4 | 7 | 36 | |
Tumor number | Â | Â | 0.426 |
Single | 10 | 36 | |
Multiple | 1 | 12 | |
TNM stage | Â | Â | 0.039* |
I–II | 12 | 34 | |
II–IV | 3 | 33 | |
Distant metastasis | Â | Â | 0.008* |
M0 | 15 | 44 | |
M1 | 0 | 23 | |
Nervous invasion | Â | Â | 0.357 |
Negative | 4 | 26 | |
Positive | 11 | 40 | |
Venous invasion | Â | Â | 0.771 |
Negative | 10 | 39 | |
Positive | 5 | 27 | |
CA199 (U/ml) | Â | Â | 0.441 |
<40 | 2 | 15 | |
≥40 | 11 | 51 | |
CA125 (U/ml) | Â | Â | 0.709 |
<35 | 8 | 36 | |
≥35 | 2 | 17 | |
Survival time(months) | 21.78(15.85–27.71) | 15.60(7.00–24.20) | 0.01* |